Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

25. September 2025 08:00 ET | Quelle: Cosmos Health Inc.

Cosmos Health Expands Order Book with Contract Manufacturing Agreement with Medical Pharmaquality S.A. for 3 Million MYCOFAGYL® Pessaries Annually

Cosmos Health expands order book with contract to manufacture 3 million units of MYCOFAGYL® pessaries, broadening its portfolio into gynecology.
22. September 2025 08:00 ET | Quelle: Cosmos Health Inc.

Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Generate Over $12M in Annualized Revenue

Cosmos Health commences U.S. operations with its Sky Premium Life brand, supported by local manufacturing capabilities. Anticipates strong cash flow.
11. September 2025 08:00 ET | Quelle: Cosmos Health Inc.

Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units

Cosmos Health signs distribution deal with Scientific Pharmacy to launch Sky Premium Life in Oman, including an initial order of 42,000 supplement units.
18. August 2025 12:45 ET | Quelle: Cosmos Health Inc.

Cosmos Health Reports Q2 2025 Results; Continues Strong Growth with 11.7% Revenue Increase; On Track to Meet Profitability Targets with Gross Profit Up 53% to $3.21M in H1 2025

Cosmos Health reported Q2 2025 results with 11.7% revenue growth and H1 gross profit up 53% to $3.21M, remaining on track with profitability targets
12. August 2025 09:50 ET | Quelle: Cosmos Health Inc.

Cosmos Health Makes Initial $1M Ethereum Purchase Under Digital Asset Treasury Strategy

Cosmos Health Makes Initial $1M Ethereum (ETH) Purchase Under Digital Asset Treasury Strategy
06. August 2025 09:20 ET | Quelle: Cosmos Health Inc.

Cosmos Health Secures up to $300 Million Financing Facility to Launch Ethereum Treasury Strategy

Cosmos Health secures financing of up to $300 million to develop an ETH-backed treasury, with remaining proceeds for growth and general working capital
24. Juni 2025 10:55 ET | Quelle: Cosmos Health Inc.

Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech

Cosmos Health expands into the U.S. with local manufacturing to reduce tariff risks, partnering with New Jersey-based DolCas Biotech for production.
15. Mai 2025 14:30 ET | Quelle: Cosmos Health Inc.

RETRANSMISSION – Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven

Cosmos Health delivered adjusted profitability in Q1 2025, with gross profit up 54% and cash burn down 95%, nearing breakeven.
15. Mai 2025 09:30 ET | Quelle: Cosmos Health Inc.

Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven

Cosmos Health delivered adjusted profitability in Q1 2025, with gross profit up 54% and cash burn down 95%, nearing breakeven.
07. Mai 2025 14:30 ET | Quelle: Cosmos Health Inc.

Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units

Cosmos Health lands follow-up order for 80K Sky Premium Life units in UAE after initial 130K sell-out, supporting 5-year goal of 3M+ units.

Vorherige Seite